Celyad Oncology SA (CLYYF)
0.245
0.00 (0.00%)
USD |
OTCM |
Nov 22, 16:00
Celyad Oncology Debt to Equity Ratio: 0.00 for June 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.00 |
| June 30, 2020 | 0.003 |
| December 31, 2019 | 0.005 |
| June 30, 2019 | 0.009 |
| December 31, 2018 | 0.0092 |
| June 30, 2018 | 0.009 |
| December 31, 2017 | 0.0113 |
| June 30, 2017 | 0.0155 |
| December 31, 2016 | 0.0082 |
| Date | Value |
|---|---|
| June 30, 2016 | 0.018 |
| December 31, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2023
0.005
Maximum
Dec 2019
0.0027
Average
0.003
Median
Jun 2020
Debt to Equity Ratio Benchmarks
| Galapagos NV | 0.00 |
| UCB SA | 0.3178 |
| Mithra Pharmaceuticals SA | -19.15 |
| Nyxoah SA | 0.1866 |
| MDxHealth SA | 3.022 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 13.23M |
| Total Liabilities (Quarterly) | 12.13M |
| Shareholders Equity (Quarterly) | 1.107M |
| Current Ratio | 1.263 |
| Net Debt Paydown Yield | 1.18% |